Molecular and transcriptional regulation of megakaryocyte differentiation

Stem Cells

Volumn 19, Issue 5, 2001, Pages 397-407

  Shivdasani, Ramesh A ^a,b  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Megakaryocyte; Platelet; Thrombopoiesis; Transcriptional regulation

Indexed keywords

ACTIN; BETA TUBULIN; TRANSCRIPTION FACTOR FLI 1; TRANSCRIPTION FACTOR FOG 1; TRANSCRIPTION FACTOR GATA 1; TRANSCRIPTION FACTOR NF E2; UNCLASSIFIED DRUG;

CELL DIFFERENTIATION; CELL MATURATION; CELL ORGANELLE; CELL VACUOLE; CHROMOSOME TRANSLOCATION; CYTOSKELETON; GENE TARGETING; HEMATOPOIESIS; HEMATOPOIETIC CELL; KNOCKOUT MOUSE; LEUKEMIA; MEGAKARYOCYTE; MICROTUBULE; MOLECULAR BIOLOGY; REVIEW; STEM CELL; THROMBOCYTE ANOMALY; THROMBOCYTE RELEASE REACTION; THROMBOCYTOPENIA; THROMBOCYTOPOIESIS; TRANSCRIPTION REGULATION;

EID: 0034812344     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1634/stemcells.19-5-397     Document Type: Review

References (101)

1. Thrombopoietin-induced polyploidization of bone marrow megakaryocytes is due to a unique regulatory mechanism in late mitosis
2. Asymmetrical segregation of chromosomes with a normal metaphase/anaphase checkpoint in polyploid megakaryocytes
3. Identification of the homologous beige and Chediak-Higashi syndrome genes
4. Mutation in AP-3 delta in the mocha mouse links endosomal transport to storage deficiency in platelets, melanosomes, and synaptic vesicles
5. The pallid gene encodes a novel, syntaxin 13-interacting protein involved in platelet storage pool deficiency
6. Rab geranylgeranyl transferase alpha mutation in the gunmetal mouse reduces Rab prenylation and platelet synthesis
7. An electron microscope study of the rat megacaryocyte II. Some aspects of platelet release and microtubules
8. The transmural passage of blood cells into myeloid sinusoids and the entry of platelets into the sinusoidal circulation: A scanning electron microscopic investigation
9. The mechanism of platelet release
10. The demarcation membrane system of the megakaryocyte: A misnomer?
11. Platelets generated in vitro from proplatelet-displaying human megakaryocytes are functional
12. Ultrastructure of platelet formation by human megakaryocytes cultured with the Mp1 ligand
13. + cells
14. Megakaryocyte fragments and the microtubule coil
15. Blood platelet formation in vitro. The role of the cytoskeleton in megakaryocyte fragmentation
16. Blood platelets are assembled principally at the ends of proplatelet processes produced by differentiated megakaryocytes
17. The transcriptional control of hematopoiesis
18. Transcription factors, normal myeloid development, and leukemia
19. Transcription factors involved in lineage-specific gene expression during megakaryopoiesis
20. Megakaryocytic and erythrocytic lineages share specific transcription factors
21. Expression of an erythroid transcription factor in megakaryocytic and mast cell lineages
22. Transcriptional regulation of the rat platelet factor 4 gene: Interaction between an enhancer/silencer domain and the GATA site
23. GATA and Ets cis-acting sequences mediate megakaryocyte-specific expression
24. Transcription factors in megakaryocyte differentiation and gene expression
25. Functional characterization of the human platelet glycoprotein V gene promoter: A specific marker of late megakaryocytic differentiation
26. A lineage-selective knockout establishes the critical role of transcription factor GATA-1 in megakaryocyte growth and platelet development
27. Familial dyserythropoietic anaemia and thrombocytopenia due to an inherited mutation in GATA1
28. Platelet characteristics in patients with X-linked macrothrombocytopenia because of a novel GATA1 mutation
29. Consequences of GATA-1 deficiency in megakaryocytes and platelets
30. FOG, a multitype zinc finger protein, acts as a cofactor for transcription factor GATA-1 in erythroid and megakaryocytic differentiation
31. Regulation of mouse p45 NF-E2 transcription by an erythroid-specific GATA-dependent intronic alternative promoter
32. Transcription factor NF-E2 is required for platelet formation independent of the actions of thrombopoietin/MGDF in megakaryocyte development
33. Mice lacking transcription factor NF-E2 validate the proplatelet model of thrombocytopoiesis and show a platelet production defect that is intrinsic to megakaryocytes
34. Inositol polyphosphate 4-phosphatase type I regulates cell growth downstream of transcription factor GATA-1
35. Use of altered specificity mutants to probe a specific protein-protein interaction in differentiation: The GATA-1:FOG complex
36. GATA-1- and FOG-dependent activation of megakaryocytic alpha IIB gene expression
37. Failure of megakaryopoiesis and arrested erythropoiesis in mice lacking the GATA-1 transcriptional cofactor FOG
38. Transcription factor GATA-2 is required for proliferation/survival of early hematopoietic cells and mast cell formation, but not for erythroid and myeloid terminal differentiation
39. Fli-1 is required for murine vascular and megakaryocytic development and is hemizygously deleted in patients with thrombocytopenia
40. The Fli-1 protooncogene, involved in erythroleukemia and Ewing's sarcoma, encodes a transcriptional activator with DNA-binding specificities distinct from other Ets family members
41. A new congenital dysmegakaryopoietic thrombocytopenia (Paris-Trousseau) associated with giant platelet alpha-granules and chromosome 11 deletion at 11q23
42. Paris-Trousseau syndrome platelets in a child with Jacobsen's syndrome
43. Erythropoiesis and globin gene expression in mice lacking the transcription factor NF-E2
44. Pathophysiology of thrombocytopenia and anemia in mice lacking transcription factor NF-E2
45. Reduced oxidative-stress response in red blood cells from p45NFE2-deficient mice
46. Impaired megakaryopoiesis and behavioral defects in mafG-null mutant mice
47. Characterization of the murine mafF gene
48. Characterization of the hematopoietic transcription factor NF-E2 in primary murine megakaryocytes
49. Dependence of globin gene expression in mouse erythroleukemia cells on the NF-E2 heterodimer
50. Perinatal synthetic lethality and hematopoietic defects in compound mafG::mafK mutant mice
51. p45 NF-E2 regulates the expression of thromboxane synthase in megakaryocytes
52. Hematopoietic-specific beta 1 tubulin participates in a pathway of platelet biogenesis dependent on the transcription factor NF-E2
53. Genomic organization, chromosomal localization, and expression of the murine thromboxane synthase gene
54. Positive or negative MARE-dependent transcriptional regulation is determined by the abundance of small Maf proteins
55. Thromboxane synthase has the same pattern of expression as platelet specific glycoproteins during human megakaryocyte differentiation
56. The mammalian β-tubulin repertoire: Hematopoietic expression of a novel β-tubulin isotype
57. The sequence and expression of the divergent β-tubulin in chicken erythrocytes
58. Free intermingling of mammalian β-tubulin isotypes among functionally distinct microtubules
59. A lineage-restricted and divergent beta-tubulin isoform is essential for the biogenesis, structure and function of blood platelets
60. Primary megakaryocytes reveal a role for transcription factor NF-E2 in integrin alpha IIb beta 3 signaling
61. Beta3-integrin-deficient mice are a model for Glanzmann thrombasthenia showing placental defects and reduced survival
62. The activation domain of the enhancer binding protein p45NF-E2 interacts with TAFII130 and mediates long-range activation of the alpha- and beta-globin gene loci in an erythroid cell line
63. The transcriptional integrator CREB-binding protein mediates positive cross talk between nuclear hormone receptors and the hematopoietic bZip protein p45/NF-E2
64. cAMP-dependent protein kinase is necessary for increased NF-E2 DNA complex formation during erythroleukemia cell differentiation
65. Stimulation of NF-E2 DNA binding by CREB-binding protein (CBP)-mediated acetylation
66. Regulation of activity of the transcription factor GATA-1 by acetylation
67. CREB-binding protein acetylates hematopoietic transcription factor GATA-1 at functionally important sites
68. The world according to Maf
69. Inherited abnormalities in platelet organelles and platelet formation and associated altered expression of low molecular weight guanosine triphosphate-binding proteins in the mouse pigment mutant gunmetal
70. Mutation of MYH9, encoding non-muscle myosin heavy chain A, in May-Hegglin anomaly
71. Mutations in MYH9 result in the May-Hegglin anomaly, and Fechmer and Sebastian syndromes
72. Mutations in the NMMHC-A gene cause autosomal dominant macrothrombocytopenia with leukocyte inclusions (May-Hegglin anomaly/ Sebastian syndrome)
73. Congenital disorders of platelet function: Disorders of signal transduction and secretion
74. Abnormal expression and subcellular distribution of subunit proteins of the AP-3 adaptor complex lead to platelet storage pool deficiency in the pearl mouse
75. Identification of mutations in the c-mp1 gene in congenital amegakaryocytic thrombocytopenia
76. Mutations in the thrombopoietin receptor, Mp1, in children with congenital amegakaryocytic thrombocytopenia
77. c-mp1 mutations are the cause of congenital amegakaryocytic thrombocytopenia
78. Thrombopoietin in patients with congenital thrombocytopenia and absent radii: Elevated serum levels, normal receptor expression, but defective reactivity to thrombopoietin
79. Existence of a differentiation blockage at the stage of a megakaryocyte precursor in the thrombocytopenia and absent radii (TAR) syndrome
80. Structure and transcription of the genomic locus encoding murine c-Mp1, a receptor for thrombopoietin
81. Analysis of the thrombopoietin receptor (MPL) promoter implicates GATA and Ets proteins in the coregulation of megakaryocyte-specific genes
82. Differential expression of homeobox genes in functionally distinct CD34+ subpopulations of human bone marrow cells
83. Overexpression of HOXA10 in murine hematopoietic cells perturbs both myeloid and lymphoid differentiation and leads to acute myeloid leukemia
84. Amegakaryocytic thrombocytopenia and radio-ulnar synostosis are associated with HOXA11 mutation
85. The t(7;11)(p 15;p 15) translocation in acute myeloid leukaemia fuses the genes for nucleoporin NUP98 and class I homeoprotein HOXA9
86. Mice bearing a targeted interruption of the homeobox gene HOXA9 have defects in myeloid, erythroid, and lymphoid hematopoiesis
87. Chromosomal translocations in human cancer
88. Involvement of a human gene related to the Drosophila spen gene in the recurrent t(1;22) translocation of acute megakaryocytic leukemia
89. Leukemia in Down syndrome: A review
90. Haploinsufficiency of CBFA2 causes familial thromhocytopenia with propensity to develop acute myelogenous leukaemia
91. AML1 and the 8;21 and 3;21 translocations in acute and chronic myeloid leukemia
92. AML-1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis
93. The CBFB subunit is essential for CBFa2 (AML1) function in vivo
94. Increased expression of the ETS-related transcription factor FLI-1/ERGB correlates with and can induce the megakaryocytic phenotype
95. Regulation of the megakaryocytic glycoprotein IX promoter by the oncogenic Ets transcription factor Fli-1
96. Unexpected and coordinated expression of Spi-1, Fli-1, and megakaryocytic genes in four Epo-dependent cell lines established from transgenic mice displaying erythroid-specific expression of a thermosensitive SV40 T antigen
97. Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages
98. Expression of tal-1 and GATA-binding proteins during human hematopoiesis
99. A functional c-myb gene is required for normal fetal hepatic hematopoiesis
100. The ski/sno protooncogene family in hematopoietic development
101. Characterization of a hipotent erythro-megakaryocytic progenitor in human bone marrow